Who should be screened for primary aldosteronism? A comprehensive review of current evidence
Abstract Arterial hypertension is a major risk factor for cardiovascular disease. The prevalence of primary aldosteronism (PA) ranges from 5% to 10% in the general hypertensive population and is regarded as one of the most common causes of secondary hypertension. There are two major causes of PA: bi...
Main Authors: | Wei‐Chieh Huang, Yen‐Hung Lin, Vin‐Cent Wu, Chen‐Huan Chen, Saulat Siddique, Yook‐Chin Chia, Jam Chin Tay, Guruprasad Sogunuru, Hao‐Min Cheng, Kazuomi Kario |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-09-01
|
Series: | The Journal of Clinical Hypertension |
Subjects: | |
Online Access: | https://doi.org/10.1111/jch.14558 |
Similar Items
-
Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
by: Chia-Hung Lin, et al.
Published: (2024-03-01) -
Who needs to be screened for primary aldosteronism?
by: Wei-Chieh Huang, et al.
Published: (2024-03-01) -
Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
by: Fabio Bioletto, et al.
Published: (2023-05-01) -
Survey of renin and aldosterone testing practices by Ontario laboratories – Providing insight into best practices
by: Angela C. Rutledge, et al.
Published: (2021-05-01) -
The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
by: Piotr Jędrusik, et al.
Published: (2021-05-01)